1. Pharmaceutical Excipients:
An important sub-segment in the plant-based excipients market, pharmaceutical excipients are non-active substances that are used in the formulation of various drugs. These excipients help in improving the stability, bioavailability, and solubility of the active pharmaceutical ingredient (API). Plant-based pharmaceutical excipients are gaining traction due to their superior functionality and natural origin. These excipients are extensively used in various dosage forms, including tablets, capsules, and parenteral formulations.
2. Nutraceutical Excipients:
Another significant sub-segment, nutraceutical excipients find application in the formulation of functional foods, dietary supplements, and other nutraceutical products. Plant-based nutraceutical excipients offer enhanced safety and efficacy compared to synthetic or animal-derived excipients. These excipients help in improving the bioavailability and stability of nutraceutical products, thereby meeting the growing consumer demand for natural and healthy products.
The plant-based excipients market is highly competitive and diverse, with several key players dominating the market. Prominent companies operating in this market include:
1. DuPont de Nemours, Inc.
2. Cargill, Incorporated
3. Roquette Frères
4. Ingredion Incorporated
5. Ashland Global Holdings Inc.
6. Merck KGaA
7. Colorcon Inc.
8. Meggle GmbH & Co. KG
9. JRS Pharma
10. Archer Daniels Midland Company
The competitive landscape of the plant-based excipients market is characterized by the presence of both global and regional players. These players focus on product innovation, strategic collaborations, and mergers and acquisitions to strengthen their market position. Furthermore, companies are investing in research and development activities to develop novel plant-based excipients with enhanced functionality and improved performance.